AHCY and atherosclerosis: SAHH inhibition by pharmacological or genetic methods significantly advanced the development of atherosclerosis and impaired endothelium-dependent vascular relaxation via epigenetic up-regulation of the p66shc-mediated oxidative stress pathway [22].